PUBLICATIONS & PATENTS |
Publications
2024
2020
2019
2018
2017
2016
2009-2015
- Chauhan G, Shaik A, Sawant S, Diwan R, Mokashi M, Goyal M, Shukla S, Kunda N, Gupta V* (2024). Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections – Development and in-vitro characterization. Biomaterials Advances I Elsevier
- Masum Z, Spoors G, Cruskie M, Bolger J, McKenzie J, Sheth P, Edwards R, Eberlin A, Markey M, Gupta V* (2024). A Stability & Polymorphic Characterization of Elacestrant Dihydrochloride. Research Square
- Chauhan G, Wang W, Quadros M, Vats M, Gupta V* (2024). Chitosan/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs. International Journal of Biological Macromolecules I Elsevier
- Shukla S, Goyal M, Kanabar D, Ayehunie S, Deore B, Sanhueza C, Muth A, Gupta V* (2024). Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex. Journal of Molecular Liquids I Elsevier
- Gadhave DG, Quadros M, Ugale AR, Goyal M, Ayehunie S, Gupta V* (2024). Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine – Development & characterization in physiologically relevant 3D tissue models. International Journal of Biological Macromolecules I Elsevier
- Wang X, Goyal M, Gadhave DG, Gupta V* (2024) Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment–Evidence in disease-relevant in-vitro models. Journal of Drug Delivery Science and Technology I Elsevier
- Yousry C, Goyal M, Gupta V* (2024). Excipients for Novel Inhaled Dosage Forms: An Overview. AAPS PharmSciTech I Springer
- Wang X, Gadhave DG, Chauhan G, Gupta V* (2023). Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique. Journal of Drug Delivery Science and Technology I Elsevier
- Gadhave DG, Quadros M, Ugale AR, Goyal M, Gupta V* (2023). A Nanoemulgel for Nose-to-Brain Delivery of Quetiapine – QbD-Enabled Formulation Development & In-vitro Characterization. International Journal of Pharmaceutics I Elsevier
- Goyal M, Tulsyan G, Kanabar D, Chavan T, Muth A, Gupta V* (2023). Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment. Journal of Drug Delivery Science and Technology I Elsevier
- Parvathaneni P, Shukla K, Gupta V* (2023). Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment. Pharmaceutics I MDPI
- Chauhan G, Wang X, Yousry C, Gupta V* (2023). Scalable Production and In Vitro Efficacy of Inhaled Erlotinib Nanoemulsion for Enhanced Efficacy in Non-Small Cell Lung Cancer (NSCLC). Pharmaceutics I MDPI
- Wang X, Chauhan C, Tacderas A, Muth A, Gupta V* (2023). Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma. International Journal of Molecular Sciences I MDPI
- Parvathaneni V, Chilamakuri R, Kulkarni NS, Baig NF, Agarwal S, Gupta V* (2022). Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment – Assessment of In-vitro Efficacy & Mechanism of Action. International Journal of Molecular Sciences (Accepted September 19, 2022).
- Sarvepalli S, Parvathaneni V, Chauhan G, Shukla SK, Gupta V* (2022). Inhaled Indomethacin-loaded Liposomes as Potential Therapeutics against Non-Small Cell Lung Cancer (NSCLC). Pharmaceutical Research (Accepted September 6, 2022) I
- Parvathaneni V, Chilamakuri R, Kulkarni NS,Wang X, Agarwal S, Gupta V* (2022). Repurposing clofazimine for malignant pleural mesothelioma treatment — In-vitro assessment of efficacy and mechanism of action. Life Sciences I ScienceDirect
- Shukla SK, Nguyen V, Goyal M, Gupta V* (2022). Cationically Modified Inhalable Nintedanib Niosomes: Enhancing Therapeutic Activity Against Non-Small Cell Lung Cancer. Nanomedicine (Accepted July 21, 2022).
- Kulkarni NS, Chauhan G, Goyal M, Sarvepalli S, Gupta V* (2022). Development of Gelatin Methacrylate (GelMa) Hydrogels for Versatile Intracavitary Applications: In-vitro Characterization and Ex-vivo Performance Assessment. Biomaterials Science (Accepted June 8th, 2022). (Invited article for Biomaterials Science Emerging Investigators Series).
- Shukla SK, Sarode A, Wang X, Mitragotri S, Gupta V* (2022). Particle shape engineering for improving safety and efficacy of doxorubicin — A case study of rod-shaped carriers in resistant small cell lung cancer. Biomaterial Advances I ScienceDirect
- Kulkarni NS, Gupta V* (2022). Repurposing therapeutics for malignant pleural mesothelioma (MPM) – Updates on clinical translations and future outlook. Life Sciences I ScienceDirect
- Parvathaneni V, Shukla SK, Kulkarni NS, Gupta V* (2021). Development and Characterization of Inhalable Transferrin Functionalized Amodiaquine Nanoparticles – Efficacy in Non-small Cell Lung Cancer (NSCLC) Treatment. International Journal of Pharmaceutics (Accepted August 20, 2021) I ScienceDirect
- Shukla SK, Sarode A, Kanabar DD, Muth A, Kunda NK, Mitragotri S, Gupta V* (2021). Bioinspired Particle Engineering for Non-invasive Inhaled Delivery to the Lungs. Material Sciences and Engineering C. (Accepted July 15, 2021) I ScienceDirect
- Parvathaneni V, Elbatanony R, Goyal M, Chavan T, Vega N, Kolluru S, Muth A, Kunda N*, Gupta V* (2021). Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes. International Journal of Molecular Sciences I ScienceDirect
- Kulkarni NS, Vaidya B, Gupta V* (2021). Nano-synergistic combination of Erlotinib and Quinacrine for non-small scale lung cancer (NSCLC) therapeutics - Evaluation in biologically relevant in-vitro models. Material Sciences and Engineering C. (Accepted January 11, 2021) I ScienceDirect
2020
- Parvathaneni V, Elbatanony R, Shukla SK, Kulkarni NS, Kanabar DD, Chauhan G, Ayehunie S, Chen Z, Muth A, Gupta V* (2020). Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activity. Journal of Molecular Liquids (Accepted November 22, 2020) I ScienceDirect
- Parvathaneni V, Kulkarni NS, Muth A, Gupta V* (2020). Therapeutic potential of inhalable medications to combat coronavirus disease-2019. Therapeutic Delivery (Accepted November, 2020) I Pubmed I Google Scholar
- Kulkarni NS, Vaidya B, Parvathaneni V, Bhanja D, Gupta V* (2020). Repurposing Quinacrine for Treatment of Malignant Mesothelioma – In-vitro Therapeutic and Mechanistic Evaluation. International Journal of Molecular Sciences (Accepted August 26, 2020) I Pubmed I Google Scholar
- Parvathaneni V, Gupta V* (2020). Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges. Life Sciences. (Accepted August 10, 2020) I ScienceDirect
- Chauhan G, Shaik AA, Kulkarni NS, Gupta V* (2020). Preparation of Lipid Based Drug Delivery Systems using Melt Extrusion. Drug Discovery Today. (Accepted July 29, 2020). I ScienceDirect I Google Scholar
- Shukla SK, Chan A, Parvathaneni V, Kanabar DD, Patel K, Muth A, Gupta V* (2020). Enhanced Solubility, Stability, Permeation and Anti-Cancer Efficacy of Celastrol-ß-Cyclodextrin Inclusion Complex. Journal of Molecular Liquids. (Accepted July 27, 2020). I Pubmed I Google Scholar
- Wang X, Parvathaneni V, Shukla SK, Kulkarni NS, Muth A, Kunda NK, Gupta V* (2020). Inhalable Resveratrol-Cyclodextrin Complex Loaded Biodegradable Nanoparticles for Enhanced Efficacy against Non-small Cell Lung Cancer. International Journal of Biological Macromolecules. (Accepted July 11, 2020). I Pubmed I Google Scholar
- Kanabar DD, Farrales P, Kabir A, Juang D, Gnanmony M, Almasri J, Torrents N, Shukla SK, Gupta V, Dukhande VV, D’Souza A, Muth A (2020). Optimizing the Aryl-triazole of cjoc42 for Enhanced Gankyrin Binding and Anti-cancer Activity. Bioorganic and Medicinal Chemistry Letters. (Accepted June 26, 2020). I ScinceDirect
- Wang X, Parvathaneni V, Shukla SK, Kanabar DD, Muth A, Gupta V* (2020). Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol – Applications in Non-Small Cell Lung Cancer Treatment. AAPS PharmSciTech (Accepted June 4, 2020). I Pubmed I Google Scholar
- Elbatanony R, Parvathaneni V, Kulkarni NS, Shukla SK, Chauhan G, Kunda NK, Gupta V* (2020). Afatinib-loaded Inhalable PLGA Nanoparticles for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC) – Development and In-vitro Efficacy. Drug Delivery and Translational Research (Accepted June 2, 2020). I Pubmed I Google Scholar
- Parvathaneni V, Goyal M, Kulkarni NS, Shukla SK, Gupta V* (2020). Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC). Pharmaceutical Research (Accepted May 28, 2020). I Pubmed I Google Scholar
- Parvathaneni V, Kulkarni NS, Chauhan G, Shukla SK, Elbatanony R, Patel BI, Kunda NK, Muth A, Gupta V* (2020). Development of Pharmaceutically Scalable Inhaled Anti-cancer Nanotherapy – Repurposing Amodiaquine for Non-Small Cell Lung Cancer (NSCLC). Materials Science and Engineering C (Accepted May 28, 2020). I Pubmed I Google Scholar
- Shukla SK, Chan A, Parvathaneni V, Gupta V* (2020). Metformin-loaded Chitosomes for Treatment of Malignant Pleural Mesothelioma – A Rare Thoracic Cancer. International Journal of Biological Macromolecules (Available online May 20, 2020). I Pubmed I Google Scholar
- Parvathaneni V, Kulkarni NS, Shukla SK, Farrales PT, Kunda NK, Muth A, Gupta V* (2020). Systemic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 12(3):206. I Pubmed I Google Scholar
- Shukla SK, Kulkarni NS, Farrales P, Kanabar DD, Parvathaneni V, Kunda NK, Muth A, Gupta V* (2020). Sorafenib Loaded Inhalable Polymeric Nanoparticles against Non-Small Cell Lung Cancer. Pharmaceutical Research 37(3):67. I Pubmed I Google Scholar
- Shukla SK, Kadry H, Bhatt J, Elbatanony R, Ahsan F, Gupta V* (2020). Statistical Optimization and Validation of a Novel UPLC Method for Estimation of Nintedanib in Rat and Human Plasma. Bioanalysis 12(3):159-174. I Pubmed I Google Scholar
- Shukla SK, Gupta V* (2020). Existing Challenges in Bioanalysis of Therapeutic Proteins. Bioanalysis (Editorial) 12(4):207-209. I Pubmed I Google Scholar
- Vaidya B, Kulkarni NS, Shukla SK, Parvathaneni V, Chauhan G, Damon JK, Sarode A, Garcia JV, Kunda NK, Mitragotri S, Gupta V* (2020). Development of Inhalable Quinacrine Loaded Bovine Serum Albumin Modified Cationic Nanoparticles: Repurposing Quinacrine for Lung Cancer Therapeutics. International Journal of Pharmaceutics 577(2020):118995. I Pubmed I Google Scholar
- Shukla SK, Gupta V* (2020). Utilizing Nanotechnology to Recuperate Sorafenib for Lung Cancer Treatment – Challenges and Future Perspective. Therapeutic Delivery (Editorial) 11(4):213-215. I Pubmed I Google Scholar
2019
- Shukla SK, Kulkarni NS, Chan A, Parvathaneni V, Farrales P, Muth A, Gupta V* (2019). Metformin Encapsulated Liposome Delivery System: An Effective Treatment Approach Against Breast Cancer. Pharmaceutics 11(11):559. I Pubmed I Google Scholar
- Parvathaneni V, Kulkarni NS, Muth A, Gupta V* (2019). Drug Repurposing: A Promising Tool to Accelerate the Drug Discovery Process. Drug Discovery Today 24(10):2076-2085. I Pubmed I Google Scholar
- Kulkarni NS, Parvathaneni V, Shukla SK, Barasa L, Perron JC, Yoganathan S, Muth A, Gupta V* (2019). Tyrosine Kinase Inhibitor Conjugated Quantum Dots for Non-Small Cell Lung Cancer (NSCLC) Treatment. European Journal of Pharmaceutical Sciences 133:145-159. I Pubmed I Google Scholar
- Kulkarni NS, Guererro Y, Gupta N, Muth A, Gupta V* (2019). Exploring Potential of Quantum Dots as Dual Modality for Cancer Therapy and Diagnosis. Journal of Drug Delivery Science and Technology 49:352-364. I Google Scholar
2018
- Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, Kanabar D, Garcia JV, Mitragotri S, Muth A, Gupta V* (2018). Cyclodextrin Modified Erlotinib Loaded PLGA Nanoparticles for Improved Therapeutic Efficacy Against Non-Small Cell Lung Cancer. International Journal of Biological Macromolecules 122:338-347. I Pubmed I Google Scholar
- Vaidya B, Shukla SK, Kolluru S, Huen M, Mulla N, Mehra N, Kanabar D, Palakurthi S, Ayehunie S, Muth A, Gupta V* (2018). Nintedanib-cyclodextrin Complex to Improve Bio-activity and Intestinal Permeability. Carbohydrate Polymers 204:68-77. I Pubmed I Google Scholar
2017
- Solomon D, Gupta N, Mulla NS, Shukla SK, Guerrero Y, Gupta V* (2017). Role of In-vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective. The AAPS Journal 19(6):1669-1681. I Pubmed I Google Scholar
- Vaidya B, Patel R, Muth A, Gupta V* (2017). Exploitation of Novel Molecular Targets to Treat Idiopathic Pulmonary Fibrosis: A Drug Discovery Perspective. Current Medicinal Chemistry 24(22):2439-2458. I Pubmed I Google Scholar
- Vaidya B, Pangallo M, Ruffenach G, Cunningham CM, Perron JC, Kolluru S, Eghbali E, Gupta V* (2017). Advances in the Treatment of Pulmonary Hypertension: A Patent Review. Expert Opinion on Therapeutic Patents 27(8):907-918. I Pubmed I Google Scholar
- Wibroe PP, Anselmo AC, Nilsson PH, Sarode A, Gupta V, Urbanics R, Szebeni J, Hunter AC, Mitragotri S, Mollnes TE, Moghimi SE (2017). Bypassing Polymeric Nanoparticle-mediated Adverse Injection Reactions through Particle Shape Control and Erythrocyte ‘Hitch-hiking’. Nature Nanotechnology 12(6):589-594. I Google Scholar
2016
- Gupta N, Liu JR, Patel BK, Solomon D, Vaidya B, Gupta V* (2016). Microfluidics-based 3D Cell Culture Models: Utility in Novel Drug Discovery and Delivery Research. Bioengineering and Translational Medicine (invited theme review for the inaugural Nanomedicine Issue) 1:63-81. I Pubmed I Google Scholar
- Pan D, Vargas-Morales O, Zern B, Anselmo AC, Gupta V, Zakrewsky M, Mitragotri S, Muzykantov V (2016). The effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells. PLoS One 11(3):e0152074. I Pubmed I Google Scholar
- Gupta V, Hwang BH, Doshi N, Banerjee A, Anselmo AC, Mitragotri S (2016). Delivery of Exenatide and Insulin using Mucoadhesive Intestinal Devices. Annals of Biomedical Engineering 44(6):19932007. I Pubmed I Google Scholar
2009-2015
- Zilbermintz L, Leonardi W, Jeong SY, Sjodt M, McComb R, Ho CL, Retterer C, Gharaibeh D, Zamani R, Soloveva V, Bavari S, Levitin A, West J, Bradley KA, Clubb RT, Cohen S, Gupta V, Martchenko M (2015). Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting. Nature Scientific Reports 5:13476. I Pubmed I Google Scholar
- Anselmo AC, Kumar S, Gupta V, Pearce AM, Ragusa A, Muzykantov V, Mitragotri S (2015). Exploiting Shape, Cellular-Hitchhiking and Antibodies to Target Nanoparticles to Lung Endothelium: Synergy between Physical, Chemical and Biological Approaches. Biomaterials 68:1-8. I Pubmed I Google Scholar
- Vaidya B, Gupta V* (2015). Novel Therapeutic Approaches for Pulmonary Arterial Hypertension: Unique Molecular Targets to Site-specific Drug Delivery. Journal of Controlled Release 211:11833. I Pubmed I Google Scholar
- Kumar L, Verma S, Vaidya B*, Gupta V* (2015). Exosomes: Natural Carriers for siRNA Delivery. Current Pharmaceutical Design 21(31):4556-65. I Pubmed I Google Scholar
- Chen M, Kumar S, Anselmo AC, Gupta V, Slee DH, Muraski JA, Mitragotri S (2015). Topical Delivery of Cyclosporin A into Skin using SPACE-peptide. Journal of Controlled Release 199:190-197. I Pubmed I Google Scholar
- Anselmo AC, Gilbert JB, Kumar S, Gupta V, Cohen RE, Rubner MF, Mitragotri S (2015). MonocyteMediated Delivery of Polymeric Backpacks to Inflamed Tissues: A Generalized Strategy to Deliver Drugs to Treat Inflammation. Journal of Controlled Release 199:29-36. I Pubmed I Google Scholar
- Vaidya B, Gupta V* (2015). Novel therapeutic strategies for cardiovascular disease treatment: From molecular level to nanotechnology. Current Pharmaceutical Design (Editorial, Theme issue on therapeutic strategies for cardiovascular disease treatment) 21(30):4367-9. I Pubmed I Google Scholar
- Chen M, Zekrewsky M, Gupta V, Anselmo AC, Muraski JA, Mitragotri S (2014). Topical Delivery of siRNA into Skin using SPACE-peptide Carriers. Journal of Controlled Release 179:33-41. I Pubmed I Google Scholar
- Anselmo AC, Gupta V, Zern B, Pan D, Muzykantov V, Mitragotri S (2013). Delivering Nanoparticles to Lungs While Avoiding Liver and Spleen through Adsorption on Red Blood Cells. ACS Nano 7(12):11129-37. I Pubmed I Google Scholar
- Chen M, Gupta V, Anselmo AC, Muraski JA, Mitragotri S (2013) Topical Delivery of Hyaluronic Acid into Skin using SPACE-peptide Carriers. Journal of Controlled Release 173:67-74. I Pubmed I Google Scholar
- Gupta V, Hwang BH, Lee J, Anselmo AC, Doshi N, Mitragotri S (2013). Mucoadhesive Intestinal Devices for Oral Delivery of Salmon Calcitonin. Journal of Controlled Release 172(3):753-762. I Pubmed I Google Scholar
- Nahar K, Gupta N, Gauvin R, Absar S, Patel BI, Gupta V, Khademhosseini A, Ahsan F (2013). In Vitro, In Vivo and Ex Vivo Models for Studying Particle Deposition and Drug Absorption of Inhaled Pharmaceuticals. European Journal of Pharmaceutical Sciences 49(5):805-818. I Pubmed I Google Scholar
- Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, Mitragotri S (2013) Using Shape Effects to Target Nanoparticles to Lung and Brain Endothelium. Proceedings of the National Academy of Sciences, USA (PNAS) 110(26):10753-8. I Pubmed I Google Scholar
- Gupta V, Hwang BH, Doshi N, Mitragotri S (2013) A Permeation Enhancer for Increasing Transport of Therapeutic Macromolecules across the Intestine. Journal of Controlled Release 172(2):541549. I Pubmed I Google Scholar
- Gupta V, Gupta N, Shaik IH, Mehvar R, Nozik-Grayck E, Mcmurtry IF, Oka M, Komatsu M, Ahsan F (2013) Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency. Molecular Pharmaceutics, 10(5):165567. I Pubmed I Google Scholar
- Gupta V, Gupta N, Shaik IH, Mehvar R, Mcmurtry IF, Oka M, Nozik-Grayck E, Komatsu M, Ahsan F (2013) Liposomal Fasudil, a Rho-Kinase Inhibitor, for Prolonged Pulmonary Preferential Vasodilation in Pulmonary Arterial Hypertension. Journal of Controlled Release, 167(2):189-99. I Pubmed I Google Scholar
- Gupta V, Doshi N, Mitragotri S (2013) Permeation of Insulin, Calcitonin and Exenatide across Caco2 Monolayers: Measurement using a Rapid, 3-Day System. PLOS One, 8(2):e57136. I Pubmed I Google Scholar
- Patel BI, Gauvin R, Absar S, Gupta V, Gupta N, Nahar K, Khademhosseini A, Ahsan F (2012) Computational and Bio-engineered Lungs as Alternatives to Whole Animal, Isolated Organ and CellBased Lung Models. American Journal of Physiology – Lung Cellular and Molecular Physiology, 303(9):L733-47. I Pubmed I Google Scholar
- Patel B, Gupta V, Ahsan F (2012) PEG-PLGA Based Large Porous Particles for Pulmonary Delivery of a Highly Soluble Drug, Low Molecular Weight Heparin. Journal of Controlled Release, 162(2):310-20. I Pubmed I Google Scholar
- Gupta V, Ahsan F (2011) Influence of PEI as a Core Modifying Agent on PLGA Microspheres of PGE1, A Pulmonary Selective Vasodilator. International Journal of Pharmaceutics, 413(1-2):5162. I Pubmed I Google Scholar
- Gupta V, Davis M, Hope-Weeks LJ, Ahsan F (2011) PLGA Microparticles Encapsulating Prostaglandin E1-Hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH). Pharmaceutical Research, 28(7):1733-49. I Pubmed I Google Scholar
- Gupta V, Ahsan F (2010) Inhalational Therapy for Pulmonary Arterial Hypertension: Current Status and Future Prospects. Critical ReviewsTM in Therapeutic Drug Carrier Systems, 27(4):313-70. I Pubmed I Google Scholar
- Gupta V, Rawat A, Ahsan F (2010) Feasibility Study of Aerosolized Prostaglandin E1 Microspheres as a Non-Invasive Therapy for Pulmonary Arterial Hypertension. Journal of Pharmaceutical Sciences, 99(4):1774-89. I Pubmed I Google Scholar
- Thomas C, Gupta V, Ahsan F (2010). Particle Size Influences the Immune Response Produced by Hepatitis B Vaccine Formulated in Inhalable Particles. Pharmaceutical Research. 27(5):905-19. I Pubmed I Google Scholar
- Bai S, Gupta V, Ahsan F (2010) Inhalable Lactose-based Dry Powder Formulations of Low Molecular Weight Heparin. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 23(2):97-104. I Pubmed I Google Scholar
- Bai S, Gupta V, Ahsan F (2009) Cationic Liposomes as Carriers for Aerosolized Formulations of an Anionic Drug: Safety and Efficacy Study. European Journal of Pharmaceutical Sciences, 38(2):165-73. I Pubmed I Google Scholar
- Thomas C, Gupta V, Ahsan F (2009) Influence of Surface Charge of PLGA Particles of Recombinant Hepatitis B Surface Antigen in Enhancing Systemic and Mucosal Immune Responses. International Journal of Pharmaceutics, 379(1):41-50. I Pubmed I Google Scholar
Book Chapters
- Goyal M, Parvathaneni V, Gupta V* (2022). Approaches for Drug Delivery to the Mitochondria – Current Status and Future Trends. Multifunctional Nanocarriers (Eds. Mehra, Srivastava, Madan and Singh): Elsevier, LLC I Google Scholar
- Wang X, Shukla SK, Gupta V* (2022). Recent Advances in Dendrimer-based Nanocarriers. Multifunctional Nanocarriers (Eds. Mehra, Srivastava, Madan and Singh): Elsevier, LLC I Google Scholar
- Kulkarni NS, Shukla SK, Gupta V* (2021). Relative Distribution of P-glycoprotein (P-gp) and its Pharmacological Relevance. An Introduction to P-Glycoproteins (Eds. Rahul Dev Jayant, and Wahajuddin): Nova Science Publishers, Hauppauge, NY, USA. I Google Scholar
- Parvathaneni V, Gupta V* (2020). Evaluation of 3D Cell Culture Models for Efficacy Determination of Anticancer Nanotherapeutics. Drug Delivery with Targeted Nanoparticles: in-vitro and in-vivo Evaluation Methods (eds. Yilmaz Capan, Hayrettin Tonbul, and Adem Sahin): Panstanford Publishing. I Google Scholar
- Parvathaneni V, Kulkarni NS, Gupta V* (2020). Current status and perspectives in mucosal drug delivery of nanotherapeutic systems. Mucosal Delivery of Drugs and Biologics in Nanoparticles in AAPS Advances in Pharmaceutical Sciences (eds. Nitesh Kunda and Pavan Muttil); Springer International Publishing AG. I Google Scholar
- Parvathaneni V, Shukla S, Gupta V* (2018). Emerging Therapeutic Targets and Therapies in Idiopathic Pulmonary Fibrosis. Fibrosis in Disease – An Organ-Based Guide to Disease Pathophysiology and Therapeutic Considerations (eds. Monte Willis, Jonathan C Schisler and Cecelia C Yates-Binder); Springer Nature Books, Switzerland AG. I Google Scholar
- Kumar L, Verma S, Vaidya B, Gupta V* (2017). Bioadhesive Polymers for Targeted Drug Delivery. Nanotechnology Based Approaches for Targeting and Delivery of Drugs and Genes (eds. Vijay Mishra, Prashant Kesharwani, Mohd Cairul, Mohd Amin, Arun Iyer). Elsevier, LLC. (In Press). I Google Scholar
- Vaidya B, Shah S, Gupta V* (2015). Drug delivery to mitochondria: Promising approach for the treatment of liver disease. Mitochondria in Liver Disease (Eds. Derick Han and Neil Kaplowitz); Taylor and Francis, LLC, New York, NY. I Google Scholar
- Gupta V, Thomas C, Ahsan F (2010) Principles and Practice of Pulmonary Drug Delivery. In Targeted Delivery of Small and Macromolecular Drugs: Problems Faced and Approaches Taken (Eds. Narang AS and Mahato RI); Taylor and Francis, LLC, New York, NY. I Google Scholar
Patents
- Gupta V, Wang X, Velaga S. Inhaled Combination Therapy for Treatment of Pulmonary Arterial Hypertension (PAH). Provisional Patent filed December 6, 2022. Application # US 63/386,111.
- Liu Q, Gupta V, Goyal M. Oral Liposomal Formulations of Fasudil. Provisional Patent filed October 6, 2022. Application # US 63/413,701.
- Kulkarni NS, Chauhan G, Gupta V. A Small-Molecule Anthelmintic for Treatment of Malignant Pleural Mesothelioma, A Rare Cancer of Lungs’ Pleural Cavity. (Provisional Patent filed June 24, 2022.) Application # US 63/366,974.
- Gupta V, Parvathaneni V, Sarvepalli S. Formulations for Oral Delivery of Polypeptides, Antibodies, and Proteins; and Uses Thereof. (Provisional Patent filed May 13, 2022.) Application # US 63/341,727.
- Gupta V, Velaga S. Combination Therapy using Ambrisentan and Tadalafil for Treatment of Pulmonary Arterial Hypertension. (Provisional Patent filed November 4, 2021.) Application # US 63/275,773.
- Gupta V. Compositions and Methods for Treating Pulmonary Fibrosis. (PCT Application Filed November 17, 2021.) Application # PCT/US21/59757.
- Gupta V. Compositions and Methods for Treating Pulmonary Fibrosis. (Provisional Patent filed November 18, 2020). Application # 63/115,106
- Gupta V. Compositions and Methods for Treating or Preventing Pulmonary Hypertension. (PCT Application Filed September 10, 2021.) Application # PCTUS2149766.
- Gupta V. Compositions and Methods for Treating or Preventing Pulmonary Hypertension. (Provisional Patent filed September 11, 2020). Application # 63/077,102
- Gupta V, Goyal M. Formulations for Oral Delivery of Polypeptides. (Provisional Patent filed April 15, 2020 by ProdigY Biotech). Application # 63/010,224
- Whitehead K, Karr N, Arora A, Mitragotri S, Gupta V. Improved Oral Drug Devices and Drug Formulations. University of California Santa Barbara (UCSB) (US Pat. App. US20130274352 A1).